CPIX Cumberland Pharmaceuticals Inc.
Stock · NasdaqGS · United States · Healthcare · US2307701092
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Cumberland Pharmaceuticals Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD.
Updated 08 Nov 2026 14:52. Information, not advice.
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 10 Nov 2026 16:00 | — | — | — | Upcoming |
| 10 Aug 2021 16:00 | -0.07 | — | +98.4% | — |
| 11 May 2021 16:00 | -0.07 | 0.07 | +200.0% | Beat |
| 09 Mar 2021 16:00 | -0.01 | 0.01 | +200.0% | Beat |
| 10 Nov 2020 16:00 | -0.07 | 0.02 | +128.6% | Beat |
| 11 Aug 2020 16:00 | 0.03 | 0.08 | +166.7% | Beat |
| 20 May 2020 16:00 | 0.02 | 0.01 | -50.0% | Miss |
| 18 Mar 2020 16:00 | 0.01 | 0.09 | +800.0% | Beat |
| 12 Nov 2019 16:00 | 0.11 | 0.01 | -90.9% | Miss |
| 14 Aug 2019 16:00 | 0.07 | 0.10 | +42.9% | Beat |
| 14 May 2019 16:00 | -0.11 | 0.11 | +200.0% | Beat |
| 26 Feb 2019 16:00 | -0.16 | 0.10 | +162.5% | Beat |
| 13 Nov 2018 16:00 | -0.19 | -0.05 | +73.7% | Beat |
| 14 Aug 2018 16:00 | -0.08 | 0.01 | +112.5% | Beat |
| 08 May 2018 16:00 | -0.02 | -0.09 | -350.0% | Miss |
| 06 Aug 2013 16:00 | 0.02 | -0.03 | -266.5% | Miss |
| 02 May 2013 16:00 | 0.05 | 0.05 | +9.1% | Beat |
| 28 Feb 2013 16:00 | 0.14 | 0.12 | -12.2% | Miss |
| 01 Nov 2012 16:00 | 0.09 | 0.10 | +16.9% | Beat |
| 02 Aug 2012 16:00 | 0.07 | 0.09 | +37.9% | Beat |
| 03 May 2012 16:00 | 0.05 | 0.02 | -61.1% | Miss |
| 29 Feb 2012 16:00 | 0.05 | 0.04 | -11.2% | Miss |
| 03 Nov 2011 16:00 | 0.06 | 0.09 | +48.3% | Beat |
| 04 Aug 2011 16:00 | 0.04 | 0.11 | +193.3% | Beat |
| 04 May 2011 16:00 | 0.03 | 0.03 | +3.1% | Beat |
| 08 Mar 2011 16:00 | 0.03 | 0.04 | +30.4% | Beat |
| 11 Nov 2010 16:00 | 0.01 | 0.05 | +261.3% | Beat |
| 16 Aug 2010 16:00 | 0.04 | 0.01 | -73.5% | Miss |
| 15 Aug 2010 20:00 | 0.02 | 0.02 | 0.0% | In line |
| 13 May 2010 16:00 | 0.02 | 0.02 | 0.0% | In line |
| 10 Mar 2010 08:00 | 0.01 | 0.01 | +11.7% | Beat |
| 10 Nov 2009 12:00 | 0.03 | 0.10 | +200.0% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 44.5M | +17.6% | -2.8M | -6.4% | -0.19 | +58.7% | 4.8M |
| 2024 | 37.9M | -4.3% | -6.5M | -17.1% | -0.46 | -4.5% | -791.9K |
| 2023 | 39.6M | -5.9% | -6.3M | -15.9% | -0.44 | -15.8% | 5.6M |
| 2022 | 42M | — | -5.6M | -13.3% | -0.38 | — | 6.4M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 02 Oct 2026 | 7.57 | 7.74 | 7.28 | 7.39 | -1.60% | 22,600 | |
| 01 Oct 2026 | 7.90 | 8.14 | 7.26 | 7.51 | -4.09% | 73,300 | |
| 30 Sep 2026 | 7.75 | 8.04 | 7.61 | 7.83 | +2.35% | 10,000 | |
| 29 Sep 2026 | 7.78 | 7.90 | 7.60 | 7.65 | -0.91% | 8,900 | |
| 28 Sep 2026 | 7.61 | 7.87 | 7.56 | 7.72 | +1.45% | 30,300 | |
| 25 Sep 2026 | 8.06 | 8.06 | 7.48 | 7.61 | -4.99% | 46,900 | |
| 24 Sep 2026 | 7.93 | 8.29 | 7.75 | 8.01 | +0.88% | 48,800 | |
| 23 Sep 2026 | 8.07 | 8.34 | 7.72 | 7.94 | -3.17% | 76,200 | |
| 22 Sep 2026 | 7.50 | 8.35 | 7.50 | 8.20 | +8.04% | 70,500 | |
| 21 Sep 2026 | 7.42 | 7.59 | 7.09 | 7.59 | +3.69% | 33,600 | |
| 18 Sep 2026 | 7.19 | 7.34 | 7.02 | 7.32 | +1.81% | 27,600 | |
| 17 Sep 2026 | 7.11 | 7.51 | 7.06 | 7.19 | +3.01% | 70,600 | |
| 16 Sep 2026 | 6.68 | 7.11 | 6.61 | 6.98 | +5.12% | 93,800 | |
| 15 Sep 2026 | 6.67 | 6.74 | 6.49 | 6.64 | -0.90% | 26,900 | |
| 14 Sep 2026 | 6.38 | 6.74 | 6.37 | 6.70 | +4.85% | 22,100 | |
| 11 Sep 2026 | 6.61 | 6.75 | 6.38 | 6.39 | -1.39% | 16,600 | |
| 10 Sep 2026 | 6.25 | 6.51 | 6.24 | 6.48 | +3.02% | 41,300 | |
| 09 Sep 2026 | 6.59 | 6.72 | 6.28 | 6.29 | -4.98% | 19,700 | |
| 08 Sep 2026 | 6.66 | 6.88 | 6.47 | 6.62 | -2.50% | 28,100 | |
| 04 Sep 2026 | 6.75 | 6.90 | 6.65 | 6.79 | +0.59% | 14,000 | |
| 03 Sep 2026 | 6.52 | 6.78 | 6.41 | 6.75 | +3.53% | 17,700 | |
| 02 Sep 2026 | 6.67 | 6.76 | 6.28 | 6.52 | -0.61% | 56,600 | |
| 01 Sep 2026 | 6.70 | 6.91 | 6.42 | 6.56 | -1.94% | 77,800 | |
| 31 Aug 2026 | 8.21 | 8.50 | 6.58 | 6.69 | -20.92% | 190,600 | |
| 28 Aug 2026 | 8.70 | 9.16 | 8.44 | 8.46 | -2.20% | 47,800 |
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q3 2026 FINANCIAL RESULTS (opens in a new tab) 03 Nov 2026 21:05
- Cumberland Pharmaceuticals Begins Rolling FDA NDA for Dyscorban in Duchenne Cardiomyopathy (opens in a new tab) MarketBeat · 26 Oct 2026 22:02
- Cumberland Pharmaceuticals stock tumbles on trial results (opens in a new tab) Investing.com · 23 Oct 2026 22:08
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 5.01 USD
- Market cap
- 78.2M
- Last dividend
- 1.5000 USD · 03 Aug 2026
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 03 Aug 2026 | 1.5000 USD |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 3.8 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 8.3 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 5.2 / 15 No figures for this part: it counts as a cautious 35%. | — |
| Quality Return on equity, net margin and how stable the margins are. | 1.8 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 0.0 / 10 | — |
| Analysts How far the analysts' average target is from today's price. | 1.8 / 5 No figures for this part: it counts as a cautious 35%. | — |
- Score capped at 50: a yield of 29% is more often a warning than a prize
- Thin interest cover: operating profit is only -5.6× the interest
- The last full year was a loss
- The price is 42% below its 52-week high: check why before relying on the yield
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 75% of the figures (grade B). Warnings take 18 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | 37.29× | Weak | 14.89× |
| Price / book | 4.48× | Weak | 3.81× |
| Price / sales | 1.77× | Good | 3.19× |
| EV / EBITDA | 71.79× | Weak | 12.63× |
| Free cash flow yield | -0.2% | Weak | 2.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 85% | Good | 58.6% |
| Operating margin | -1,898.7% | Weak | 7.8% |
| Net margin | -24.6% | Weak | 2.8% |
| Return on equity | -14.4% | Weak | 5.7% |
| Return on assets | -2.9% | Weak | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 2% | Weak | 10.8% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.28× | Good | 0.48× |
| Net debt / EBITDA | 0.78× | Good | 1.6× |
| Interest cover | -5.63× | Weak | 2.69× |
| Current ratio | 0.96× | Weak | 2.39× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow CPIX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.